Stock Screener App

Frei -

Installieren

13.06

4.31% 0.54

after-market

Handel nachbörslich: 13.16 0.10 +0.77%

Generate Biomedicines Inc (GENB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Generate Biomedicines Inc-Aktie (GENB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
Revenues	12.60% 6.314	7.224
Operating Expenses	9.24% 77.93	71.34
Depreciation and Amortization	2.23% 3.20	3.273
Operating Income/Loss	11.70% -71.61	-64.11
Nonoperating Income/Loss	81.86% 4.412	2.426
Income/Loss From Continuing Operations Before Tax	8.94% -67.20	-61.69
Income Tax Expense/Benefit	89.29% 0.053	0.028
Net Income/Loss	8.98% -67.25	-61.71
Attributable To Noncontrolling Interest	100.00% -	-0.268
Basic Average Shares	97.68% 128.24	64.87
Diluted Average Shares	97.68% 128.24	64.87
Basic Earnings Per Share	51.40% -0.52	-1.07
Diluted Earnings Per Share	51.40% -0.52	-1.07

NUVB

$4.75

1.50%

ZBIO

$25.40

2.17%

TRVI

$12.11

0.41%

BHVN

$11.43

4.57%

OCUL

$7.38

2.50%

SEPN

$37.45

3.11%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters